Applicability of a structure-based modelling approach as a tool for in silico screening of oligonucleotides for targeted RNA editing presented at Oligonucleotide Therapeutics Society (OTS) 2018 by Julien Boudet
… Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that the … October 8 – 10, 2015 and the 11 th Annual Meeting of the OligonucleotideTherapeuticsSociety (OTS) in Leiden, The Netherlands, October 11 – 14, …
… the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … two investor conferences during the month of September. OligonucleotideTherapeuticsSociety During the 12 th Annual Meeting of the …
… interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on central … Axiomer ® RNA editing technology platform at the OligonucleotideTherapeuticsSociety (OTS) meeting in Bordeaux, France and at the Drug …
